Genetic Testing Plays Larger Role in Treatment of Prostate Cancer
Heather H. Cheng, MD, PhD, discusses the role of genetic testing in prostate cancer as it continues to evolve in this space. This year, the 2019 NCCN guidelines focused more on genetic testing in select patients with prostate cancer.
Heather H. Cheng, MD, PhD, an associate professor of medical oncology at the University of Washington School of Medicine, and director of the Seattle Cancer Care Alliance Prostate Cancer Genetics Clinic, discusses the role of genetic testing in prostate cancer as it continues to evolve in this space. This year, the2019 National Comprehensive Cancer Network (NCCN) guidelinesfocused more on genetic testing in select patients with prostate cancer.
Genetic testing, genetic counseling, and issues surround genetics are taking on a larger role in the realm of prostate cancer, Cheng says. It is making an impact in primary care, urology, internal medicine, and oncology. Genetic testing provides new opportunities for patients with prostate cancer.
